机构

• 自动化研究所 [2]
• 心理研究所 [1]
• 合肥物质科学研究院 [1]

采集方式

• OAI收割 [4]

_filter

_filter

_filter

筛选

浏览/检索结果: 共4条，第1-4条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials 期刊论文  OAI收割 SCIENCE CHINA-LIFE SCIENCES, 2024 作者:  Wang, Jinliang;  Zhou, Wenyong;  Xu, Yu;  Duan, Jianchun;  Zhou, Qiaoxia   |  收藏  |  浏览/下载：5/0  |  提交时间：2024/11/20 non-squamous NSCLC  squamous NSCLC  LRP1B deleterious mutations  predictive biomarker  immune checkpoint inhibitor   Screening for depression and anxiety in lung cancer patients: A real-world study using GAD-7 and HADS 期刊论文  OAI收割 THORACIC CANCER, 2024, 页码: 9 作者:  Chau, Yi Fung;  Zhou, Huixia;  Chen, Bolu;  Ren, Hengqin;  Ma, Zixiao   |  收藏  |  浏览/下载：20/0  |  提交时间：2024/05/05 anxiety  depression  lung cancer  psychology  Psycho-Oncology   Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文  OAI收割 BMC Medicine, 2022, 卷号: 20, 期号: 1 作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/11/21 Tucidinostat  Tumor microenvironment  PD-L1  CCL5  Solid tumor   Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma 期刊论文  OAI收割 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 15 作者:  He, Xiran;  Du, Yang;  Wang, Zhijie;  Wang, Xin;  Duan, Jianchun   |  收藏  |  浏览/下载：186/0  |  提交时间：2021/01/06 drug therapy  combination  immunotherapy  lung neoplasms  lymphocytes  tumor-infiltrating  translational medical research